Dicot Pharma AB (NGM: DICOT)

Dicot Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	155	260	46	71	46	46
Market Cap Growth	160.87%	464.37%	-35.49%	56.49%	-0.03%	62.75%
Enterprise Value	138	215	32	54	28	44
Last Close Price	0.19	0.32	0.34	0.69	1.04	2.79
PE Ratio	-	-3.81	-1.27	-1.64	-1.70	-2.07
PS Ratio	-	-	-	-	-	73.12
PB Ratio	8.89	5.86	8.60	2.52	2.32	3.57
P/FCF Ratio	-5.99	-5.75	-1.55	-2.76	-2.80	-3.09
P/OCF Ratio	-5.99	-5.75	-1.55	-2.76	-2.81	-3.09
EV/Sales Ratio	-	-	-	-	-	70.01
EV/EBITDA Ratio	-5.32	-4.78	-0.99	-2.00	-1.59	-
EV/EBIT Ratio	-5.32	-4.78	-0.99	-2.00	-1.59	-3.28
EV/FCF Ratio	-5.37	-4.76	-1.06	-2.10	-1.71	-2.96
Asset Turnover	-	-	-	-	-	0.05
Quick Ratio	1.98	5.42	1.50	9.16	10.88	10.10
Current Ratio	2.67	5.84	1.76	9.28	11.06	11.03
Return on Equity (ROE)	-144.43%	-177.51%	-188.41%	-113.20%	-108.08%	-127.04%
Return on Assets (ROA)	-75.54%	-85.39%	-90.05%	-63.81%	-61.53%	-69.31%
Return on Capital (ROIC)	-92.48%	-113.15%	-117.93%	-70.95%	-67.64%	-79.02%
Earnings Yield	-36.19%	-16.98%	-68.93%	-38.05%	-38.44%	-29.35%
FCF Yield	-16.71%	-17.40%	-64.50%	-36.22%	-35.71%	-32.33%
Buyback Yield / Dilution	-179.40%	-336.53%	-89.21%	-124.32%	-187.81%	-56.75%
Total Shareholder Return	-179.40%	-336.53%	-89.21%	-124.32%	-187.81%	-56.75%

Source: S&P Capital IQ. Standard template. Financial Sources.